BioNTech SE Quarterly Liabilities in EUR from Q4 2018 to Q4 2023

Taxonomy & unit
ifrs-full: EUR
Summary
BioNTech SE quarterly Liabilities history and growth rate from Q4 2018 to Q4 2023.
  • BioNTech SE Liabilities for the quarter ending December 31, 2023 was €2.76B, a 14.4% decline year-over-year.
Liabilities, Quarterly (EUR)
Liabilities, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 2.76B -463M -14.4% Dec 31, 2023 20-F 2024-03-20
Q4 2022 3.22B -714M -18.1% Dec 31, 2022 20-F 2024-03-20
Q4 2021 3.94B +2.99B +316% Dec 31, 2021 20-F 2023-03-27
Q4 2020 947M +643M +211% Dec 31, 2020 20-F/A 2022-10-26
Q4 2019 304M -81.8M -21.2% Dec 31, 2019 20-F 2021-03-30
Q4 2018 386M Dec 31, 2018 20-F 2020-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.